I was recently asked about the use of vaccines and adalimumab (Humira). More specifically, can we give vaccines if the patient is taking a biologic agent like adalimumab? It isn’t a simple yes or no answer as it depends upon the type of vaccine. More...
To be 100% transparent, I have never personally seen a case of tendon rupture that was likely due to quinolones. I have heard of one from another colleague. It is a very rare adverse effect that has been reported in numerous case studies. What I want you to be aware...
As much as I would like to say I’ve never seen a patient have a pressure ulcer infection, I have. Pressure ulcer infections can be an issue in my geriatric population. There are numerous clinical pearls to remember in managing these types of infections. First...
Ciprofloxacin (Cipro) has historically been used on a regular basis for urinary tract infections. That frequency of use changed a few years back when the boxed warnings for serious adverse effects came out. I wanted to provide my top ciprofloxacin clinical pearls that...
Clindamycin is an antibiotic that has been around for a long time. There are quite a few quirks with this medication and I wanted to cover my top 5 clindamycin clinical pearls that may show up on board exams and in clinical practice. C. Diff Risk Let’s start...
It is that time of the year with creepy/crawly ticks running rampant. This presents an excellent opportunity to go over some of my Lyme disease clinical practice pearls! You never know when these might show up on a board exam! Lyme Disease Clinical Practice Pearls...
